MI
Therapeutic Areas
Bonesupport Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CERAMENT G | Infection prevention in open fractures (Inpatient) | Commercial |
| CERAMENT BONE VOID FILLER | Non-infected bone voids | Commercial |
| CERAMENT V | Bone infection (Vancomycin-sensitive) | Commercial (ex-U.S.) |
| CERTiFy Clinical Trial | Clinical evidence generation | Post-Market Study |
Leadership Team at Bonesupport
TS
Torbjörn Sköld
Chief Executive Officer
HJ
Håkan Johansson
Chief Financial Officer
AA
Annelie Aava Vikner
EVP Global Marketing
HB
Helena Brandt
EVP Human Resources
MD
Michael Diefenbeck
EVP Medical & Clinical Affairs, Chief Medical Officer
FM
Fergus MacLeod
GM & EVP Commercial Operations EUROW
LJ
Lennart Johansson
Chairman of the Board
BO
Björn Odlander
Board Member
CR
Christine Rankin
Board Member
JV
Jens Viebke
Board Member